Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V0251 oral suspension in acute vestibular neuritis
2010-023099-13Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vestibular neuritis comparing V0251 (L-acetylleucine) with Placebo (2 arms). Primary endpoints: Vertigo Symptom Scale – Short Form (VSS-SF) and Verbal Rating Scale (VRS) for vertigo. Started Dec 2010; status: completed.
02
Drugs
levacetylleucine
03
Conditions
vestibular neuritis
Beyond the preview
Go deeper on 2010-023099-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023099-13.